wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30984472-4BCFD4FD-B1F6-4BCB-800E-713CA196E999
Q30984472-4BCFD4FD-B1F6-4BCB-800E-713CA196E999
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30984472-4BCFD4FD-B1F6-4BCB-800E-713CA196E999
Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness.
P2860
Q30984472-4BCFD4FD-B1F6-4BCB-800E-713CA196E999
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30984472-4BCFD4FD-B1F6-4BCB-800E-713CA196E999
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
528ee41763e4e00768942fcaccce6230bc80d8ca
P2860
Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group.